Temporary liver coating may improve safety and targeting of mRNA vaccines and cancer therapies

AIMode News Desk · curated summary

August 20, 20261 min readScience

Automated news aggregation. Headlines and summaries are gathered from public feeds; see our editorial standards for sourcing, corrections, and AI-assist disclosure.

With the commercialization of mRNA vaccines against COVID-19, research and development into the application of mRNA in vaccines and pharmaceuticals is accelerating. In particular, it is attracting attention not only in vaccines for preventing infectious diseases but also in cancer immunotherapy.

Key takeaways

01With the commercialization of mRNA vaccines against COVID-19, research and development into the application of mRNA in vaccines and pharmaceuticals is accelerating.
02In particular, it is attracting attention not only in vaccines for preventing infectious diseases but also in cancer immunotherapy.

About this story

This story was aggregated from Phys.org. Headlines, summaries, and links are gathered automatically from public RSS feeds for your convenience.

Read the full story →

For agents:JSON record OpenAPI WebMCP llms.txt

Newton's momentum principles could help design safer offshore facilities in extreme waves

Researchers have developed a novel model to accurately and efficiently predict the impact of "green water"—water washing onto the deck of an offshore facility during extreme wave conditions.

Phys.org · 46 minutes ago

Science

Oxygen vacancies unlock fast lithium-ion transport in battery material

Lithium titanate (LTO, Li4Ti5O12) is a well-established battery material that in its pristine state is a poor conductor of lithium ions. It develops high ionic conductivity only during charging, when additional lithium ions and electrons are incorporated into the material.

Phys.org · 46 minutes ago

Science